FDA approves diabetes drug that also helps with weight loss

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

TRENTON, N.J. — U.S. regulators have approved a new diabetes drug that reduces blood sugar levels and also helps people lose weight.

The Food and Drug Administration on Tuesday approved the once-a-week shot for people with Type 2 diabetes.

Danish drugmaker Novo Nordisk says the drug will cost about the same as similar drugs at $676 for a four- to six-week supply without insurance.

The drug, called Ozempic (oh-ZEHM’-pic), comes in injector pens. It stimulates insulin production and reduces appetite.

On average, the medicine reduced long-term blood sugar levels at least 2 ½ times as much as a popular daily diabetes pill in one big study. It also helped study participants lose two to three times as much weight as those in the comparison group given Merck & Co.’s Januvia.